Koji Inaba
Papers
1
Total Citations
6
H-Index
1
About
Koji Inaba is a leading figure in radiation oncology, with a focused expertise in ultrahypofractionated treatments for prostate cancer. His major contributions center on optimizing high-precision radiotherapy techniques, particularly through comparative analyses of high-dose-rate brachytherapy (HDR-BT) and stereotactic body radiotherapy (SBRT). In his most cited work, a 2023 treatment planning comparison, Inaba systematically evaluated dosimetric differences between HDR-BT, robotic SBRT, and conventional SBRT for ultrahypofractionated prostate cancer therapy. This study provides critical guidance for clinicians selecting the most effective and safe radiation modality, directly impacting patient outcomes by balancing tumor control with normal tissue sparing. While his citation count is still growing, reflecting the recent publication of his key work, his research is already shaping clinical decision-making in a rapidly evolving field. Inaba’s meticulous approach to treatment planning underscores his commitment to advancing precision oncology, making him a valuable contributor to the ongoing refinement of prostate cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1